THE GENOMIC RESPONSE OF TUMOR-CELLS TO HYPOXIA AND REOXYGENATION - DIFFERENTIAL ACTIVATION OF TRANSCRIPTION FACTORS AP-1 AND NF-KAPPA-B

被引:156
作者
RUPEC, RA [1 ]
BAEUERLE, PA [1 ]
机构
[1] UNIV FREIBURG, INST BIOCHEM, D-79104 FREIBURG, GERMANY
来源
EUROPEAN JOURNAL OF BIOCHEMISTRY | 1995年 / 234卷 / 02期
关键词
NF-KAPPA-B; AP-1; HYPOXIA; REOXYGENATION; TRANSCRIPTION;
D O I
10.1111/j.1432-1033.1995.632_b.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hypoxia and reoxygenation are important pathophysiological conditions that occur during injury, ischemia, reperfusion and stroke. In tumors, hypoxia and oxidative stress are regarded as triggers for enhanced proliferation and metastasis. Hypoxia and reoxygenation exert part of their biological effects by inducing the expression of novel genes but very little is known about the transcription factors involved. Here, we have compared the behaviour of two redox-controlled factors, AP-1 and NF-kappa B, during hypoxia and reoxygenation. We report that the DNA-binding and transcriptional activity of transcription factor AP-1 is very strongly induced in a biphasic response when HeLa cells are exposed to reduced oxygen pressure. This induction required new AP-1 protein synthesis. Different members of the Jun/Fos family of transcription factors were found in the first and second maxima of activation. The pathogen-responsive, pre-existing transcription factor NF-kappa B was not activated under hypoxic conditions. However, a p50-p65 heterodimer of NF-kappa B was rapidly and strongly activated when HeLa cells were re-exposed to normal oxygen pressure. This explains the induction of NF-kappa B-controlled inflammatory cytokine genes during reperfusion of ischemic tissue. Our data suggest that the genomic response to hypoxia is primarily mediated by AP-1 while the inflammatory response to reoxygenation is mediated by NF-kappa B.
引用
收藏
页码:632 / 640
页数:9
相关论文
共 60 条
[21]   TIME COURSE AND MECHANISM OF OXIDATIVE STRESS AND TISSUE-DAMAGE IN RAT-LIVER SUBJECTED TO INVIVO ISCHEMIA-REPERFUSION [J].
GONZALEZFLECHA, B ;
CUTRIN, JC ;
BOVERIS, A .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (02) :456-464
[22]   SIGNAL-TRANSDUCTION FROM THE CELL-SURFACE TO THE NUCLEUS THROUGH THE PHOSPHORYLATION OF TRANSCRIPTION FACTORS [J].
KARIN, M .
CURRENT OPINION IN CELL BIOLOGY, 1994, 6 (03) :415-424
[23]   HYPOXIC TUMOR-CELL - TARGET FOR SELECTIVE CANCER-CHEMOTHERAPY [J].
KENNEDY, KA ;
TEICHER, BA ;
ROCKWELL, S ;
SARTORELLI, AC .
BIOCHEMICAL PHARMACOLOGY, 1980, 29 (01) :1-8
[24]  
KINDY MS, 1991, J MOL NEUROSCI, V2, P217
[25]  
KOONG AC, 1994, CANCER RES, V54, P1425
[26]   OXYGEN-TENSION REGULATES THE EXPRESSION OF THE PLATELET-DERIVED GROWTH FACTOR-B CHAIN GENE IN HUMAN ENDOTHELIAL-CELLS [J].
KOUREMBANAS, S ;
HANNAN, RL ;
FALLER, DV .
JOURNAL OF CLINICAL INVESTIGATION, 1990, 86 (02) :670-674
[27]   PURIFIED TRANSCRIPTION FACTOR AP-1 INTERACTS WITH TPA-INDUCIBLE ENHANCER ELEMENTS [J].
LEE, W ;
MITCHELL, P ;
TJIAN, R .
CELL, 1987, 49 (06) :741-752
[28]  
LI Y, 1992, J BIOL CHEM, V267, P15097
[29]   HYPOXIA INDUCES GLUCOSE TRANSPORTER EXPRESSION IN ENDOTHELIAL-CELLS [J].
LOIKE, JD ;
CAO, L ;
BRETT, J ;
OGAWA, S ;
SILVERSTEIN, SC ;
STERN, D .
AMERICAN JOURNAL OF PHYSIOLOGY, 1992, 263 (02) :C326-C333
[30]  
MEYER M, 1994, MCBU, P217